JPWO2021007465A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021007465A5 JPWO2021007465A5 JP2022502022A JP2022502022A JPWO2021007465A5 JP WO2021007465 A5 JPWO2021007465 A5 JP WO2021007465A5 JP 2022502022 A JP2022502022 A JP 2022502022A JP 2022502022 A JP2022502022 A JP 2022502022A JP WO2021007465 A5 JPWO2021007465 A5 JP WO2021007465A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- nucleic acid
- acid sequence
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962872084P | 2019-07-09 | 2019-07-09 | |
| US62/872,084 | 2019-07-09 | ||
| PCT/US2020/041473 WO2021007465A2 (fr) | 2019-07-09 | 2020-07-09 | Traitement du cancer faisant appel à des formulations pharmaceutiques d'parni ciblées pour réguler à la baisse l'expression de la protéine prdm14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545055A JP2022545055A (ja) | 2022-10-25 |
| JPWO2021007465A5 true JPWO2021007465A5 (fr) | 2023-07-19 |
Family
ID=74115310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502022A Pending JP2022545055A (ja) | 2019-07-09 | 2020-07-09 | ＰＲＤＭ１４タンパク質の発現をダウンレギュレートする標的化ｓｉＲＮＡ製剤を使用する癌処置 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220267775A1 (fr) |
| EP (1) | EP3996684A2 (fr) |
| JP (1) | JP2022545055A (fr) |
| CN (1) | CN114727958B (fr) |
| WO (1) | WO2021007465A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113616593A (zh) * | 2021-08-23 | 2021-11-09 | 嘉兴学院 | 一种纳米靶向聚合物胶束在制备靶向给药系统中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011050178A2 (fr) * | 2009-10-21 | 2011-04-28 | Lonnie Bookbinder | Agents thérapeutiques de modulation ciblée de gènes ou protéines prdm |
| US9273316B2 (en) * | 2010-05-21 | 2016-03-01 | Peptimed, Inc. | Reagents and methods for treating cancer |
| JP6189215B2 (ja) * | 2010-11-01 | 2017-08-30 | ペプチメッド， インコーポレイテッド | 細胞特異的ターゲティングのためのペプチドに基づいたシステムの組成物 |
| WO2015051214A1 (fr) * | 2013-10-03 | 2015-04-09 | Moderna Therapeutics, Inc. | Polynucléotides codant pour un récepteur de lipoprotéines de faible densité |
| WO2016065273A1 (fr) * | 2014-10-24 | 2016-04-28 | The University Of Chicago | Domaines de protéines thermo-inductibles à auto-assemblage |
-
2020
- 2020-07-09 EP EP20836336.6A patent/EP3996684A2/fr active Pending
- 2020-07-09 CN CN202080063192.4A patent/CN114727958B/zh active Active
- 2020-07-09 JP JP2022502022A patent/JP2022545055A/ja active Pending
- 2020-07-09 WO PCT/US2020/041473 patent/WO2021007465A2/fr unknown
-
2022
- 2022-01-07 US US17/571,251 patent/US20220267775A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2197885T3 (es) | Uso de inhibidores csf-1. | |
| CN104781271A (zh) | 具有生物可逆的基团的多核苷酸 | |
| EP3679139B1 (fr) | Compositions stabilisées de petits arn activateurs (parna) de hnf4a et procédés d'utilisation | |
| MX2011000227A (es) | Composiciones y metodos para inhibir la expresion de genes del receptor de factor de crecimiento por transformacion-beta. | |
| CA2692155A1 (fr) | Compositions comprenant un arnsi de egfr humain et leurs procedes d'utilisation | |
| US20240018519A1 (en) | Stabilized saRNA Compositions and Methods of Use | |
| KR20100131509A (ko) | Ｒｎａ 간섭 효과가 높은 2본쇄 지질 수식 ｒｎａ | |
| CN107530439B (zh) | 用于治疗癌症的对人抗原R表达的siRNA抑制 | |
| JP6033218B2 (ja) | がんを治療するための試薬および方法 | |
| US20220281911A1 (en) | Oligonucleotide conjugate compositions and methods of use | |
| ES2363500T3 (es) | Arn interferente para el gen znfn3a1 como método para inhibir el crecimiento de células cancerosas. | |
| WO2012173994A2 (fr) | Formulations de modification de phase de charges utiles d'acide nucléique | |
| JPWO2021007465A5 (fr) | ||
| JP3289912B2 (ja) | ポリアミノ酸オリゴヌクレオチドキャリヤー | |
| US20220267775A1 (en) | CANCER TREATMENT USING TARGETED siRNA PHARMACEUTICAL FORMULATIONS TO DOWNREGULATE EXPRESSION OF PRDM14 PROTEIN | |
| WO2011111874A1 (fr) | Arn du type en forme d'haltère et à perméation de membrane cellulaire et son procédé de fabrication | |
| Yin et al. | Asymmetric siRNA targeting the bcl‑2 gene inhibits the proliferation of cancer cells in vitro and in vivo | |
| US20150329857A1 (en) | Rna interference to activate stem cells | |
| EP2064328A2 (fr) | Sensibilisation des cellules de cancer à la thérapie en utilisant le sina visant des gènes des régions 1p et 19q chromosomiques | |
| WO2014169087A2 (fr) | Traitement de l'atrophie musculaire spinale proximale | |
| KR101595152B1 (ko) | Ｔｃｔｐ-ｐｔｄ를 포함하는 유전자 전달체 | |
| US11655474B2 (en) | Suppression of pathological angiogenesis by inhibition of NR2F6 | |
| US20240150764A1 (en) | Therapeutic splice-switching oligonucleotides for cancer | |
| Bazaz | Enhancing the efficiency of viral and non-viral gene delivery vectors | |
| CN104630223B (zh) | 包含POKEMON基因的siRNA的运输载体颗粒及其制备方法 |